These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16102024)

  • 1. Determinants of the interindividual variability in response to antiplatelet drugs.
    Rocca B; Patrono C
    J Thromb Haemost; 2005 Aug; 3(8):1597-602. PubMed ID: 16102024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of clopidogrel on "aspirin specific" pathways of platelet inhibition.
    Hobson AR; Qureshi Z; Banks P; Curzen NP
    Platelets; 2009 Sep; 20(6):386-90. PubMed ID: 19811222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet responsiveness to clopidogrel in patients with coronary syndrome. Comparison of platelet aggregation induced by ADP and flow cytometric analysis of intraplatelet VASP phosphorylation].
    Morel O; Viellard C; Faure A; Jesel L; Ohlmann P; Desprez D; Chauvin M; Roul G; Grunebaum L; Bareiss P
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):21-9. PubMed ID: 17343035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normalization of platelet reactivity in clopidogrel-treated subjects.
    Vilahur G; Choi BG; Zafar MU; Viles-Gonzalez JF; Vorchheimer DA; Fuster V; Badimon JJ
    J Thromb Haemost; 2007 Jan; 5(1):82-90. PubMed ID: 17239165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The genetics of antiplatelet drug resistance.
    Feher G; Feher A; Pusch G; Lupkovics G; Szapary L; Papp E
    Clin Genet; 2009 Jan; 75(1):1-18. PubMed ID: 19067731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiplatelet resistance with aspirin and clopidogrel: is it real and does it matter?
    Chen WH
    Curr Cardiol Rep; 2006 Jul; 8(4):301-6. PubMed ID: 16822366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring antiplatelet drug effects in the laboratory.
    Harrison P; Frelinger AL; Furman MI; Michelson AD
    Thromb Res; 2007; 120(3):323-36. PubMed ID: 17239428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.
    Kawamura M; Imura Y; Moriya N; Kita S; Fukushi H; Sugihara H; Nishikawa K; Terashita Z
    J Pharmacol Exp Ther; 1996 Apr; 277(1):502-10. PubMed ID: 8613960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of platelet function in healthy cats in response to commonly prescribed antiplatelet drugs using three point-of-care platelet function tests.
    Ho KK; Abrams-Ogg AC; Wood RD; O'Sullivan ML; Kirby GM; Blois SL
    J Feline Med Surg; 2017 Jun; 19(6):638-647. PubMed ID: 27170631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention: the role of dual drug resistance.
    Lev EI; Patel RT; Maresh KJ; Guthikonda S; Granada J; DeLao T; Bray PF; Kleiman NS
    J Am Coll Cardiol; 2006 Jan; 47(1):27-33. PubMed ID: 16386660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to antiplatelet therapy.
    Guthikonda S; Lev EI; Kleiman NS
    Curr Cardiol Rep; 2005 Jul; 7(4):242-8. PubMed ID: 15987620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet resistance to antiplatelet drugs.
    Kumar A; Kao J
    Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):98-108. PubMed ID: 19519552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that pre-existent variability in platelet response to ADP accounts for 'clopidogrel resistance'.
    Michelson AD; Linden MD; Furman MI; Li Y; Barnard MR; Fox ML; Lau WC; McLaughlin TJ; Frelinger AL
    J Thromb Haemost; 2007 Jan; 5(1):75-81. PubMed ID: 17002661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.
    Würtz M; Grove EL
    Curr Pharm Des; 2012; 18(33):5344-61. PubMed ID: 22724409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to aspirin and clopidogrel monitored with different platelet function methods.
    Mani H; Linnemann B; Luxembourg B; Kirchmayr K; Lindhoff-Last E
    Platelets; 2006 Aug; 17(5):303-10. PubMed ID: 16928602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of aspirin and clopidogrel resistance in patients undergoing percutaneous coronary interventions.
    Pregowski J; Witkowski A; Sitkiewicz D
    Curr Vasc Pharmacol; 2007 Apr; 5(2):135-40. PubMed ID: 17430218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of 96-well plate aggregometry and measurement of thrombi adhesion to determine aspirin and clopidogrel effectiveness.
    Armstrong PC; Dhanji AR; Truss NJ; Zain ZN; Tucker AT; Mitchell JA; Warner TD
    Thromb Haemost; 2009 Oct; 102(4):772-8. PubMed ID: 19806265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variable platelet response to aspirin and new therapeutic targets].
    Richard S; Toussaint-Hacquard M; Lecompte T
    J Mal Vasc; 2009 Feb; 34(1):16-25. PubMed ID: 19110389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.